These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 11073721)

  • 1. A multicenter study of women with nonclassical congenital adrenal hyperplasia: relationship between genotype and phenotype.
    Speiser PW; Knochenhauer ES; Dewailly D; Fruzzetti F; Marcondes JA; Azziz R
    Mol Genet Metab; 2000 Nov; 71(3):527-34. PubMed ID: 11073721
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of different genotypes on 17-hydroxyprogesterone levels in patients with nonclassical congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
    Bachega TA; Billerbeck AE; Marcondes JA; Madureira G; Arnhold IJ; Mendonca BB
    Clin Endocrinol (Oxf); 2000 May; 52(5):601-7. PubMed ID: 10792340
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phenotype-genotype correlation in 56 women with nonclassical congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
    Deneux C; Tardy V; Dib A; Mornet E; Billaud L; Charron D; Morel Y; Kuttenn F
    J Clin Endocrinol Metab; 2001 Jan; 86(1):207-13. PubMed ID: 11232002
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Steroid Screening Tools Differentiating Nonclassical Congenital Adrenal Hyperplasia and Polycystic Ovary Syndrome.
    Maffazioli GDN; Bachega TASS; Hayashida SAY; Gomes LG; Valassi HPL; Marcondes JAM; Mendonca BB; Baracat EC; Maciel GAR
    J Clin Endocrinol Metab; 2020 Aug; 105(8):. PubMed ID: 32530459
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical and molecular characterization of a cohort of 161 unrelated women with nonclassical congenital adrenal hyperplasia due to 21-hydroxylase deficiency and 330 family members.
    Bidet M; Bellanné-Chantelot C; Galand-Portier MB; Tardy V; Billaud L; Laborde K; Coussieu C; Morel Y; Vaury C; Golmard JL; Claustre A; Mornet E; Chakhtoura Z; Mowszowicz I; Bachelot A; Touraine P; Kuttenn F
    J Clin Endocrinol Metab; 2009 May; 94(5):1570-8. PubMed ID: 19208730
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The spectrum of clinical, hormonal and molecular findings in 280 individuals with nonclassical congenital adrenal hyperplasia caused by mutations of the CYP21A2 gene.
    Livadas S; Dracopoulou M; Dastamani A; Sertedaki A; Maniati-Christidi M; Magiakou AM; Kanaka-Gantenbein C; Chrousos GP; Dacou-Voutetakis C
    Clin Endocrinol (Oxf); 2015 Apr; 82(4):543-9. PubMed ID: 25041270
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Steroid biomarkers for identifying non-classic adrenal hyperplasia due to 21-hydroxylase deficiency in a population of PCOS with suspicious levels of 17OH-progesterone.
    Oriolo C; Fanelli F; Castelli S; Mezzullo M; Altieri P; Corzani F; Pelusi C; Repaci A; Di Dalmazi G; Vicennati V; Baldazzi L; Menabò S; Dormi A; Nardi E; Brillanti G; Pasquali R; Pagotto U; Gambineri A
    J Endocrinol Invest; 2020 Oct; 43(10):1499-1509. PubMed ID: 32236851
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-classic adrenal hyperplasia due to the deficiency of 21-hydroxylase and its relation to polycystic ovarian syndrome.
    Pignatelli D
    Front Horm Res; 2013; 40():158-70. PubMed ID: 24002412
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hyperandrogenism in carriers of CYP21 mutations: the role of genotype.
    Admoni O; Israel S; Lavi I; Gur M; Tenenbaum-Rakover Y
    Clin Endocrinol (Oxf); 2006 Jun; 64(6):645-51. PubMed ID: 16712666
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutational spectrum of steroid 21-hydroxylase and the genotype-phenotype association in Middle European patients with congenital adrenal hyperplasia.
    Dolzan V; Sólyom J; Fekete G; Kovács J; Rakosnikova V; Votava F; Lebl J; Pribilincova Z; Baumgartner-Parzer SM; Riedl S; Waldhauser F; Frisch H; Stopar-Obreza M; Krzisnik C; Battelino T
    Eur J Endocrinol; 2005 Jul; 153(1):99-106. PubMed ID: 15994751
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CYP21A2 genotypes do not predict the severity of hyperandrogenic manifestations in the nonclassical form of congenital adrenal hyperplasia.
    Moura-Massari VO; Bugano DD; Marcondes JA; Gomes LG; Mendonca BB; Bachega TA
    Horm Metab Res; 2013 Apr; 45(4):301-7. PubMed ID: 23322511
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Results of the ACTH stimulation test in hirsute women.
    Erel CT; Senturk LM; Oral E; Mutlu H; Colgar U; Seyisoglu H; Ertungealp E
    J Reprod Med; 1999 Mar; 44(3):247-52. PubMed ID: 10202742
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The presence of the 21-hydroxylase deficiency carrier status in hirsute women: phenotype-genotype correlations.
    Escobar-Morreale HF; San Millán JL; Smith RR; Sancho J; Witchel SF
    Fertil Steril; 1999 Oct; 72(4):629-38. PubMed ID: 10521100
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genotype and hormonal phenotype in nonclassical 21-hydroxylase deficiency.
    Speiser PW; New MI
    J Clin Endocrinol Metab; 1987 Jan; 64(1):86-91. PubMed ID: 3023431
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Classical and nonclassical 21-hydroxylase deficiency: a molecular study of Argentine patients.
    Dain LB; Buzzalino ND; Oneto A; Belli S; Stivel M; Pasqualini T; Minutolo C; Charreau EH; Alba LG
    Clin Endocrinol (Oxf); 2002 Feb; 56(2):239-45. PubMed ID: 11874416
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genotype-phenotype associations in non-classical steroid 21-hydroxylase deficiency.
    Weintrob N; Brautbar C; Pertzelan A; Josefsberg Z; Dickerman Z; Kauschansky A; Lilos P; Peled D; Phillip M; Israel S
    Eur J Endocrinol; 2000 Sep; 143(3):397-403. PubMed ID: 11022183
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predicting phenotype in steroid 21-hydroxylase deficiency? Comprehensive genotyping in 155 unrelated, well defined patients from southern Germany.
    Krone N; Braun A; Roscher AA; Knorr D; Schwarz HP
    J Clin Endocrinol Metab; 2000 Mar; 85(3):1059-65. PubMed ID: 10720040
    [TBL] [Abstract][Full Text] [Related]  

  • 18. p.H62L, a rare mutation of the CYP21 gene identified in two forms of 21-hydroxylase deficiency.
    Menassa R; Tardy V; Despert F; Bouvattier-Morel C; Brossier JP; Cartigny M; Morel Y
    J Clin Endocrinol Metab; 2008 May; 93(5):1901-8. PubMed ID: 18319307
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The prevalence of non-classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency in Russian women with hyperandrogenism.
    Grodnitskaya E; Kurtser M
    Hum Fertil (Camb); 2018 Dec; 21(4):281-287. PubMed ID: 28669219
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Variable ACTH-stimulated 17-hydroxyprogesterone values in 21-hydroxylase deficiency carriers are not related to the different CYP21 gene mutations.
    Bachega TA; Brenlha EM; Billerbeck AE; Marcondes JA; Madureira G; Arnhold IJ; Mendonca BB
    J Clin Endocrinol Metab; 2002 Feb; 87(2):786-90. PubMed ID: 11836321
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.